Used in pharmaceutical research as an intermediate in the synthesis of serotonin receptor modulators, particularly targeting 5-HT2A and 5-HT2C receptors. It plays a role in developing compounds for neurological and psychiatric disorders such as depression, anxiety, and schizophrenia. Its structure supports the design of small molecule therapeutics with improved selectivity and blood-brain barrier penetration. Also investigated for potential anticonvulsant and anti-migraine applications due to its interaction with central nervous system pathways.